Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Cristea, Ioana A
and
Naudet, Florian
2019.
US Food and Drug Administration approval of esketamine and brexanolone.
The Lancet Psychiatry,
Vol. 6,
Issue. 12,
p.
975.
Bennabi, D.
Charpeaud, T.
Yrondi, A.
Genty, J.-B.
Destouches, S.
Lancrenon, S.
Alaïli, N.
Bellivier, F.
Bougerol, T.
Camus, V.
Dorey, J.-M.
Doumy, O.
Haesebaert, F.
Holtzmann, J.
Lançon, C.
Lefebvre, M.
Moliere, F.
Nieto, I.
Rabu, C.
Richieri, R.
Schmitt, L.
Stephan, F.
Vaiva, G.
Walter, M.
Leboyer, M.
El-Hage, W.
Llorca, P.-M.
Courtet, P.
Aouizerate, B.
and
Haffen, E.
2019.
Clinical guidelines for the management of treatment-resistant depression: French recommendations from experts, the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental.
BMC Psychiatry,
Vol. 19,
Issue. 1,
Browne, Caroline A.
and
Lucki, Irwin
2019.
Targeting opioid dysregulation in depression for the development of novel therapeutics.
Pharmacology & Therapeutics,
Vol. 201,
Issue. ,
p.
51.
Češková, Eva
and
Šilhán, Petr
2020.
Treatment options for pharmacoresistant depression in routine clinical practice.
Psychiatrie pro praxi,
Vol. 21,
Issue. 3,
p.
124.
Cosci, Fiammetta
Guidi, Jenny
Mansueto, Giovanni
and
Fava, Giovanni A.
2020.
Psychotherapy in recurrent depression: efficacy, pitfalls, and recommendations.
Expert Review of Neurotherapeutics,
Vol. 20,
Issue. 11,
p.
1169.
Jacobson, Moriah L.
Wulf, Hildegard A.
Browne, Caroline A.
and
Lucki, Irwin
2020.
The kappa opioid receptor antagonist aticaprant reverses behavioral effects from unpredictable chronic mild stress in male mice.
Psychopharmacology,
Vol. 237,
Issue. 12,
p.
3715.
Jahrami, Haitham
Bragazzi, Nicola Luigi
Grant, William Burgess
AlFarra, Hala Shafeeq Mohamed
AlFara, Wafa Shafeeq Mohamed
Mashalla, Shahla
and
Saif, Zahra
2020.
Vitamin D Doses from Solar Ultraviolet and Dietary Intakes in Patients with Depression: Results of a Case-Control Study.
Nutrients,
Vol. 12,
Issue. 9,
p.
2587.
Browne, Caroline A.
Jacobson, Moriah L.
and
Lucki, Irwin
2020.
Novel Targets to Treat Depression: Opioid-Based Therapeutics.
Harvard Review of Psychiatry,
Vol. 28,
Issue. 1,
p.
40.
Sayegh, Liliane
Touré, El Hadj
Farquhar, Elisabeth
Beaulieu, Serge
Renaud, Suzane
Rej, Soham
and
Perreault, Michel
2020.
Group Cognitive Behavioral Analysis System of Psychotherapy (CBASP): A Pilot Study for Bipolar Depression.
Frontiers in Psychiatry,
Vol. 11,
Issue. ,
Owens, M.
Watkins, E.
Bot, M.
Brouwer, I. A.
Roca, M.
Kohls, E.
Penninx, B. W. J. H.
van Grootheest, G.
Hegerl, U.
Gili, M.
and
Visser, M.
2020.
Nutrition and depression: Summary of findings from the EU‐funded MooDFOOD depression prevention randomised controlled trial and a critical review of the literature.
Nutrition Bulletin,
Vol. 45,
Issue. 4,
p.
403.
Madison, Caitlin A.
and
Eitan, Shoshana
2020.
Buprenorphine: prospective novel therapy for depression and PTSD.
Psychological Medicine,
Vol. 50,
Issue. 6,
p.
881.
Cuijpers, Pim
Karyotaki, Eirini
Eckshtain, Dikla
Ng, Mei Yi
Corteselli, Katherine A.
Noma, Hisashi
Quero, Soledad
and
Weisz, John R.
2020.
Psychotherapy for Depression Across Different Age Groups: A Systematic Review and Meta-analysis.
JAMA Psychiatry,
Vol. 77,
Issue. 7,
p.
694.
Fava, Giovanni A.
Cosci, Fiammetta
Guidi, Jenny
and
Rafanelli, Chiara
2020.
The Deceptive Manifestations of Treatment Resistance in Depression: A New Look at the Problem.
Psychotherapy and Psychosomatics,
Vol. 89,
Issue. 5,
p.
265.
Yavi, Mani
Henter, Ioline D.
Park, Lawrence T
and
Zarate, Carlos
2021.
Key considerations in the pharmacological management of treatment-resistant depression.
Expert Opinion on Pharmacotherapy,
Vol. 22,
Issue. 17,
p.
2405.
Bartova, Lucie
Fugger, Gernot
Dold, Markus
Swoboda, Marleen Margret Mignon
Zohar, Joseph
Mendlewicz, Julien
Souery, Daniel
Montgomery, Stuart
Fabbri, Chiara
Serretti, Alessandro
and
Kasper, Siegfried
2021.
Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the European Group for the Study of Resistant Depression.
Journal of Psychiatric Research,
Vol. 141,
Issue. ,
p.
167.
Mansueto, Giovanni
and
Cosci, Fiammetta
2021.
Major Depressive Disorder.
Vol. 1305,
Issue. ,
p.
351.
Liu, Jialing
Xun, Zhiyuan
and
Khalaf, Osamah Ibrahim
2021.
Evaluation of the Effect of Comprehensive Nursing in Psychotherapy of Patients with Depression.
Computational and Mathematical Methods in Medicine,
Vol. 2021,
Issue. ,
p.
1.
Høstmælingen, Andreas
Ulvenes, Pål
Nissen‐Lie, Helene Amundsen
Eielsen, Mikkel
and
Wampold, Bruce E.
2021.
Comparing outcomes in chronic depression following inpatient psychotherapy for patients continuing versus discontinuing antidepressant medication.
Clinical Psychology & Psychotherapy,
Vol. 28,
Issue. 5,
p.
1111.
McIntyre, Roger S
Lipsitz, Orly
Lui, Leanna M W
Rodrigues, Nelson B
Lee, Yena
Ho, Roger C
Subramaniapillai, Mehala
Gill, Hartej
Cha, Danielle S
Lin, Kangguang
Teopiz, Kayla M
Nasri, Flora
Mansur, Rodrigo B
Kratiuk, Kevin
and
Rosenblat, Joshua D
2021.
Does pre-treatment functioning influence response to intravenous ketamine in adults with treatment-resistant depression?.
Journal of Affective Disorders,
Vol. 292,
Issue. ,
p.
714.
McIntyre, Roger S.
Rosenblat, Joshua D.
Nemeroff, Charles B.
Sanacora, Gerard
Murrough, James W.
Berk, Michael
Brietzke, Elisa
Dodd, Seetal
Gorwood, Philip
Ho, Roger
Iosifescu, Dan V.
Lopez Jaramillo, Carlos
Kasper, Siegfried
Kratiuk, Kevin
Lee, Jung Goo
Lee, Yena
Lui, Leanna M.W.
Mansur, Rodrigo B.
Papakostas, George I.
Subramaniapillai, Mehala
Thase, Michael
Vieta, Eduard
Young, Allan H.
Zarate, Carlos A.
and
Stahl, Stephen
2021.
Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation.
American Journal of Psychiatry,
Vol. 178,
Issue. 5,
p.
383.